STOCK TITAN

Vita Coco (COCO) COO sells 60,000 shares, retains options and 57,910 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth executed an exercise-and-sell trading pattern under a Rule 10b5-1 trading plan. On April 29–30, 2026, he exercised options to acquire 60,000 shares of common stock at an exercise price of about $10.178 per share and sold 60,000 shares in open-market transactions at prices ranging from $62.50 to $67.50 per share. Following these transactions, he directly owns 57,910 shares of common stock and retains several non-qualified stock option awards with exercise prices between $10.178 and $33.36 per share expiring between 2030 and 2035.

Positive

  • None.

Negative

  • None.
Insider Burth Jonathan
Role Chief Operating Officer
Sold 60,000 shs ($3.90M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (Right to Buy) 20,000 $0.00 --
Exercise Common Stock 20,000 $10.178 $204K
Sale Common Stock 20,000 $67.50 $1.35M
Exercise Non-Qualified Stock Option (Right to Buy) 20,000 $0.00 --
Exercise Non-Qualified Stock Option (Right to Buy) 20,000 $0.00 --
Exercise Common Stock 20,000 $10.178 $204K
Sale Common Stock 20,000 $65.00 $1.30M
Exercise Common Stock 20,000 $10.178 $204K
Sale Common Stock 20,000 $62.50 $1.25M
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 73,575 shares (Direct, null); Common Stock — 77,910 shares (Direct, null)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable. The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Shares sold 60,000 shares Total Vita Coco common shares sold in open-market trades
Sale prices $62.50–$67.50/share Reported sale prices for common stock on April 29–30, 2026
Exercise price $10.178/share Exercise price for non-qualified stock options converted to common stock
Post-transaction holdings 57,910 shares Common shares directly owned after latest reported transaction
Remaining option exercise range $10.178–$33.36 Exercise prices of remaining non-qualified stock options
Option expiration range 2030–2035 Expiration dates of remaining non-qualified stock options
Rule 10b5-1 trading plan financial
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option (Right to Buy) financial
"security_title": "Non-Qualified Stock Option (Right to Buy)""
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
exercise price financial
"conversion_or_exercise_price": "10.1780""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burth Jonathan

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/29/2026M20,000A$10.17877,910D
Common Stock04/29/2026S(1)20,000D$6577,910D
Common Stock04/29/2026M20,000A$10.17897,910D
Common Stock04/29/2026S(1)20,000D$62.557,910D
Common Stock04/30/2026M20,000A$10.17877,910D
Common Stock04/30/2026S(1)20,000D$67.557,910D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$10.17804/29/2026M20,000 (2)02/10/2030Common Stock20,000$0113,575D
Non-Qualified Stock Option (Right to Buy)$10.17804/29/2026M20,000 (2)02/10/2030Common Stock20,000$093,575D
Non-Qualified Stock Option (Right to Buy)$10.17804/30/2026M20,000 (2)02/10/2030Common Stock20,000$073,575D
Non-Qualified Stock Option (Right to Buy)$10.178 (3)02/10/2030Common Stock40,95040,950D
Non-Qualified Stock Option (Right to Buy)$10.178 (2)01/11/2031Common Stock34,12534,125D
Non-Qualified Stock Option (Right to Buy)$15 (4)10/21/2031Common Stock58,04358,043D
Non-Qualified Stock Option (Right to Buy)$15.36 (5)08/15/2032Common Stock42,98042,980D
Non-Qualified Stock Option (Right to Buy)$16.91 (6)03/10/2033Common Stock14,02514,025D
Non-Qualified Stock Option (Right to Buy)$16.91 (7)03/10/2033Common Stock14,20514,205D
Non-Qualified Stock Option (Right to Buy)$26.18 (8)03/04/2034Common Stock8,7468,746D
Non-Qualified Stock Option (Right to Buy)$33.36 (9)03/04/2035Common Stock13,21813,218D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option is fully vested and currently exercisable.
3. The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
4. The stock option vests in four equal annual installments beginning on November 27, 2022.
5. The stock option vests in three equal annual installments beginning on August 15, 2025.
6. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
7. The stock option vests in four equal annual installments beginning on March 10, 2024.
8. The stock option vests in four equal annual installments beginning on March 4, 2025.
9. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
/s/ Alison Klein, attorney-in-fact for Jonathan Burth05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Vita Coco (COCO) report for COO Jonathan Burth?

Jonathan Burth reported option exercises and share sales. He exercised options for 60,000 Vita Coco common shares at about $10.178 each, then sold 60,000 shares in open-market trades at prices between $62.50 and $67.50 per share under a Rule 10b5-1 plan.

How many Vita Coco (COCO) shares did the COO sell and at what prices?

The COO sold 60,000 Vita Coco common shares. Open-market sales occurred on April 29–30, 2026 at prices of $62.50, $65.00, and $67.50 per share, according to the Form 4 transaction data and related summary fields.

How many Vita Coco (COCO) shares does the COO hold after these transactions?

After the transactions, the COO holds 57,910 shares. The Form 4 shows total shares of Vita Coco common stock directly owned following the most recent reported transaction as 57,910 shares, reflecting his remaining direct equity position.

Were the Vita Coco (COCO) COO’s sales made under a Rule 10b5-1 plan?

Yes, the COO’s share sales used a Rule 10b5-1 plan. A footnote states the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan, indicating they were pre-arranged rather than discretionary market-timing decisions.

What option exercise price did the Vita Coco (COCO) COO pay for exercised shares?

The exercised options carried a $10.178 exercise price. Multiple transactions show non-qualified stock options with a conversion or exercise price of $10.178 per share, which were exercised into common stock before the related open-market sales.

What unexercised stock options does the Vita Coco (COCO) COO still hold?

The COO retains several non-qualified stock option grants. Remaining awards cover underlying Vita Coco common shares with exercise prices from $10.178 to $33.36 per share and expiration dates ranging from 2030 to 2035, according to the derivative position summary.